Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer

Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Hadji P, Tesch H, Ettl J, Lueftner D, Mueller V, Welslau M, Belleville E, Brucker SY, Schuetz F, Fasching P, Fehm TN, Schneeweiss A, Kolberg HC (2018)

Publication Type: Journal article

Publication year: 2018

Journal

Geburtshilfe und Frauenheilkunde Georg Thieme Verlag

Book Volume: 78

Pages Range: 1110-1118

Journal Issue: 11

DOI: 10.1055/a-0715-2821

Abstract

In primary early breast cancer, the aim of treatment planning is to obtain an increasingly better understanding of the disease. The identification of patients with an excellent prognosis could help this group avoid unnecessary treatments. Furthermore, the planning of treatment is becoming increasingly patient-focussed. There is a growing understanding of those patients who benefit particularly from chemotherapy, as well as of those who could benefit from immunotherapy. Studies conducted on immunotherapies will be published shortly. Smaller individual studies offer an initial insight into the efficacy of checkpoint inhibitors (anti-PD1/PDL1 therapies). Not least, one of the largest breast cancer studies of all times has recently come to an end. The use of a multigene test has shown that it is sufficient to identify patients with such a good prognosis that chemotherapy is unnecessary. This review article is intended to summarise the current studies and give an outlook on current developments.

Authors with CRIS profile

Naiba Nabieva Department of Obstetrics and Gynaecology Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Universitätsklinikum Würzburg DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) Eberhard Karls Universität Tübingen DE Germany (DE) OncoConsult DE Germany (DE) Krankenhaus Nordwest DE Germany (DE) Centrum für Hämatologie und Onkologie Bethanien DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE) Klinikum Aschaffenburg DE Germany (DE) ClinSol GmbH & Co.KG DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Universitätsklinikum Düsseldorf DE Germany (DE) Marienhospital Bottrop DE Germany (DE)

How to cite

APA:

Woeckel, A., Lux, M.P., Janni, W., Hartkopf, A.D., Nabieva, N., Taran, F.-A.,... Kolberg, H.-C. (2018). Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer. Geburtshilfe und Frauenheilkunde, 78(11), 1110-1118. https://doi.org/10.1055/a-0715-2821

MLA:

Woeckel, Achim, et al. "Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer." Geburtshilfe und Frauenheilkunde 78.11 (2018): 1110-1118.

BibTeX: Download